Note: The award owner's name is highlighted with blue.


 

Award in 2015

 

1.

Liang C.One-year   studentship provided by the “Mr. Kwok Yat Wai and Madam Kwok Chung Bo Fun   Graduate School Development Fund”, 2015.

2.

Liang C, Guo B, Wu H,   Zhang L, Lu A, Zhang G. Aptamer-functionalized delivery system for osteogenic   siRNAs to achieve osteoblast-specific RNA interference for bone anabolic   therapy. 2015 Orthopaedic Research Society (ORS) annual meeting, Las Vegas,   March 28-31, 2015. Certificate.

3.

Liu J, Dang L, Li D,   Guo B, Lu A, Zhang G. A delivery system specifically approaching bone   resorption surfaces to facilitate therapeutic modulation of miRNAs in   osteoclasts. Poster Abstract, Young Investigator Award, ICMRS Conference and   Xiangya Osteoporosis Forum, Changsha, China, Apr 9-11, 2015. Certificate

4.

Liang C, Xu M, Xu J, Zhang B, Lu A, Zhang G. Discovery of   Small Molecules to Promote BMP Signaling and Bone Formation. 6th   Sino-American Symposium on Clinical and Translational Medicine (SAS-CTM).   Abstract. Clinical and Translational Medicine Excellent Thesis Awards.

5.

Liang C, ASBMR Young Investigator Award for the European Calcified   Tissue Society (ECTS) Ph.D. Training Course. University of Siena, Tuscany,   Italy. September 13-16, 2015.

 

Award in 2014

 

1.

Zhang GeInvestigation of regulatory mechanism of ubiquitin   ligases and their  application in the treatment of osteoporosis. Chinese   Medical Science and Technology Award. (Second class). 2014.

2.

Zhang Ge. Investigation of   molecular function,   regulatory mechanism and disease correlation of ubiquitin ligases. Beijing   Science and Technology  Awards (First class). 2014. Certificate.

3.

Zhang Ge. Modernization of   traditional   anti-osteoporosis Chinese medicine. National Science   &   Technology Progress Award (Second class). 2014.  Certificate.

4.

Liang C, Guo B, Wu H,   Zhang L, Lu A, Zhang G.    Aptamer-Functionalized  Lipid Nanoparticles   (LNPs)   Targeting  Osteoblasts as a Novel RNA  Interference-Based Bone   Anabolic Strategy.   ASBMR 2014 Annual Meeting. Oral  Presentation     Abstract. Young  Investigator Award. September   12-15,  2014.

5.

Liang C, Guo B, Wu H,   Zhang L, Lu A, Zhang G.     Aptamer-Functionalized  Lipid Nanoparticles   (LNPs) Targeting     Osteoblasts as a Novel RNAi-Based Bone  Anabolic  Strategy.   5th   Sino-American Symposium on Clinical and Translational    Medicine   (SAS-CTM). Abstract. Clinical and Translational   Medicine  Excellent Thesis Awards.

6.

Dang L, Guo B, Li D,   Lu A, Zhang G. A    Peptide-functionalized delivery system to target   osteoclasts.   ASBMR 2014.  Poster Presentation Abstract. Young Investigator   Travel Grant Award.  September 11-15, 2014.

7.

Baosheng Guo, Liu Jin,   Dang   lei, Liang Chao,   Xiaohua Pan,  Lingqiang Zhang, Aiping Lu, Baoting Zhang, Ge Zhang.   Up-regulated CKIP-1 expression within osteoblasts associates with reduced BMP   signaling and  decreased   bone formation during aging, The   excellent thesis award. The   5th   Sino-American   Symosium on Clinical and  Translational   Medicine, May 31,     2014, Beijing. Certificate.

8.

Liang C, Guo B, Wu H,   Zhang L, Lu A, Zhang G.    Aptamer-Functionalized  Lipid   Nanoparticles (LNPs)   Targeting Osteoblasts  as a Novel RNAi-Based Bone  Anabolic   Strategy. Webster Jee Travel Award. the 7th  international    Conference on Osteoporosis and Bone Research, Oct 16-19,    Xiamen, China.

 

Award in 2013

 

1.

Jin Liu, Does  age-related increase in CKIP-1   within mesenchymal stem cells associate with  age-related impairment in   fracture repair ?, Oral Presentation Award (2nd Prize),    Postgraduate Research  Symposium on Regenerative Medicine 2013,   Guangzhou, China, 2013. Certificate.

2.                      

Biao LiuToward  targeted therapy in advanced   pancreatic cancer: a smart triptolide-nucleolin  aptamer    conjugate, Oral Presentation  Award (3nd Prize),    Postgraduate Research Symposium on Regenerative  Medicine 2013,    Guangzhou, China, 2013.  Certificate.